Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-23-052736

Options or other derivatives

  • Director acquired 7,375 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mahony Susan Director 2023-10-10 Grant or award · Stock Option (Right to Buy) +1,502 1,502 D
Mahony Susan Director 2023-10-10 Grant or award · Stock Option (Right to Buy) +5,873 5,873 D
Loading xslF345X05/doc4.xml…